Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Aayush Wellness Ltd

AAYUSH
BSE
39.00
2.23%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Aayush Wellness Ltd

AAYUSH
BSE
39.00
2.23%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
190Cr
Close
Close Price
39.00
Industry
Industry
Trading
PE
Price To Earnings
41.94
PS
Price To Sales
1.47
Revenue
Revenue
129Cr
Rev Gr TTM
Revenue Growth TTM
153.81%
PAT Gr TTM
PAT Growth TTM
85.60%
Peer Comparison
How does AAYUSH stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
AAYUSH
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
0011142622234045
Growth YoY
Revenue Growth YoY%
104.2179.573.7
Expenses
ExpensesCr
0011132521223944
Operating Profit
Operating ProfitCr
000111110
OPM
OPM%
2.16.44.35.32.31.40.9
Other Income
Other IncomeCr
000000111
Interest Expense
Interest ExpenseCr
000000000
Depreciation
DepreciationCr
000000000
PBT
PBTCr
000111111
Tax
TaxCr
000000000
PAT
PATCr
000111111
Growth YoY
PAT Growth YoY%
3,533.3541.2364.031.5-3.7
NPM
NPM%
2.36.44.34.95.13.02.4
EPS
EPS
0.00.00.10.20.20.20.20.30.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025TTM
Revenue
RevenueCr
173129
Growth
Revenue Growth%
12,063.576.5
Expenses
ExpensesCr
070127
Operating Profit
Operating ProfitCr
033
OPM
OPM%
59.44.52.1
Other Income
Other IncomeCr
002
Interest Expense
Interest ExpenseCr
000
Depreciation
DepreciationCr
000
PBT
PBTCr
135
Tax
TaxCr
000
PAT
PATCr
135
Growth
PAT Growth%
488.634.0
NPM
NPM%
94.84.63.5
EPS
EPS
0.10.70.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
355
Reserves
ReservesCr
236
Current Liabilities
Current LiabilitiesCr
000
Non Current Liabilities
Non Current LiabilitiesCr
005
Total Liabilities
Total LiabilitiesCr
5916
Current Assets
Current AssetsCr
116
Non Current Assets
Non Current AssetsCr
4710
Total Assets
Total AssetsCr
5916

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-10
Investing Cash Flow
Investing Cash FlowCr
00
Financing Cash Flow
Financing Cash FlowCr
00
Net Cash Flow
Net Cash FlowCr
-10
Free Cash Flow
Free Cash FlowCr
-10
CFO To PAT
CFO To PAT%
-99.311.3
CFO To EBITDA
CFO To EBITDA%
-158.611.4

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
57273
Price To Earnings
Price To Earnings
99.981.3
Price To Sales
Price To Sales
95.03.7
Price To Book
Price To Book
11.633.0
EV To EBITDA
EV To EBITDA
159.281.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.06.1
OPM
OPM%
59.44.5
NPM
NPM%
94.84.6
ROCE
ROCE%
12.140.5
ROE
ROE%
11.640.6
ROA
ROA%
11.438.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Aayush Wellness Limited, formerly known as Aayush Food and Herbs Limited (rebranded in June 2024), is undergoing a strategic transformation to become a fully integrated health and wellness solutions provider. The company is leveraging a multi-vertical, technology-enabled model combining traditional Indian wellness practices with modern innovations in nutraceuticals, diagnostics, digital health, and wellness tourism. With a pan-India presence and an expanding global footprint, Aayush Wellness is positioned at the intersection of preventive healthcare, lifestyle wellness, and digital transformation, aiming to capture growth across domestic and international markets. --- ### **Core Business Segments & Strategic Initiatives (2024–2025)** #### **1. Nutraceutical & Wellness Product Portfolio Expansion** Aayush Wellness has significantly deepened its presence in the fast-growing nutraceutical space with science-backed, consumer-centric products: - **Dreamy Sleep Gummies (launched Aug 2024):** Targets the rising prevalence of sleep disorders in India (nearly 49% report frequent sleep issues). Positioned as a premium, tasty solution for millennials and Gen Z, addressing a market expected to exceed $75 billion by 2033 (India: $32B in 2024, ~10% CAGR). - **Beauty Vitamin Gummies (launched Sep 2025):** Taps into the $28 billion Indian beauty and personal care market (projected $34B by 2028), capturing the fast-growing "beauty-from-within" segment (8% CAGR), valued at $6.98B by 2028. - **Brain Fuel Capsules (launched Jul 2025):** Addresses cognitive fatigue, mental clarity, and memory retention—key concerns among students, professionals, and the aging population. Targets the $18B Indian nutraceutical market growing at >15% CAGR. #### **2. Strategic Rebranding & Market Positioning** The shift from *Aayush Food and Herbs* to *Aayush Wellness Limited* reflects a deliberate pivot from traditional herbal products to a holistic, preventive healthcare brand. The company now operates across five diversified business verticals: - Nutraceuticals - Herbal & Ayurvedic Products - Diagnostics (Aayush Labs) - Digital Health (Telemedicine & E-Health Platform) - Wellness Tourism This diversified model reduces operational risk, improves revenue visibility, and strengthens resilience amid market volatility. --- ### **Digital Health & Integrated Ecosystem (Aayush Health & Aayush Labs)** #### **Aayush Health – Digital Healthcare Platform (Launched Jul 2025)** - A comprehensive teleconsultation and patient management platform accessible via web and mobile app. - Offers video consultations with verified doctors, electronic medical records, prescription management, insurance support, medicine delivery, and integrated smart health ATM services. - Designed to improve healthcare access in Tier 2 and Tier 3 cities, where medical infrastructure and specialist availability are limited. - Enters the $1.62 billion telemedicine market (21.2% CAGR). #### **Aayush Labs – Diagnostics Expansion** - Offers wide-ranging preventive and chronic care diagnostic tests. - Key differentiator: Home sample collection—a high-growth service contributing ~25% of industry expansion. - Utilizes AI-enabled diagnostic tools, including **smart Health ATMs** capable of delivering results in 2–3 minutes (first launched in Virar, Maharashtra, May 2025). - Follows an **asset-light, scalable model**, enabling rapid expansion with lower capex and higher ROIC. - Generates recurring revenue, facilitates upselling of wellness plans and nutraceuticals, and enhances personalized care through data-driven insights. --- ### **Omni-Channel Distribution & E-Commerce Growth** Aayush Wellness is aggressively building a seamless omnichannel presence: - **E-commerce Listings:** Products available on Amazon.in, Flipkart.com, and its own platform (www.aayushwellness.com). - **Digital Expansion:** Strategic listing of **Aayush Herbal Pan Masala** and **Beauty Vitamin Gummies** on major platforms to reach Tier II/III customers amid rising e-commerce adoption. - **Low-Cost Innovation:** Introduction of ₹10 herbal pan masala sachets to increase affordability and drive mass-market adoption through kirana stores and general trade. - **Direct-to-Consumer (D2C):** Strong focus on digital engagement, personalized offers, and direct delivery across urban and rural India. --- ### **Strategic Partnerships & Rapid Delivery Network** #### **Partnership with Blinkit (Nov 2025)** - A landmark collaboration with India’s leading quick-commerce platform, Blinkit. - Leverages Blinkit’s hyperlocal delivery network for **instant, in-minutes delivery** of health and wellness products. - Enables real-time product availability, improves inventory efficiency, and enhances customer experience. - Supports transition into an omnichannel, tech-driven healthcare brand with scalable last-mile reach. --- ### **International Expansion & Global Footprint** #### **Export Business & Singapore Subsidiary** - Incorporated **Aayush Worldwide Private Limited (Jan 2025)** and **AAYUSH INTERNATIONAL PTE. LTD. in Singapore (Oct 2025)**. - Secured **$3 million export order from Cosmos Holdings Pte Ltd (Dec 2024, confirmed Sep 2025)**—a gateway to the Singapore market and broader ASEAN region. - Singapore subsidiary serves as a **regional hub** for: - Faster regulatory clearances - Distribution efficiency in Southeast Asia - Localization of products for ASEAN markets (Malaysia, Indonesia, Thailand, Vietnam) - Access to a $3 trillion ASEAN economy and a $10 billion wellness ecosystem. - Targets Southeast Asia’s nutraceutical market (projected $15.1B by 2028, 7.5% CAGR) and positions India as a global source for Ayurvedic and herbal wellness products. #### **Global Market Potential** - Global nutraceutical market: $498B (2024) → $850B by 2030. - Global Ayurvedic & herbal market: Expected to reach $24B by 2025. - Singapore’s health supplement market: $202.8M (2024), growing at 3.81% annually. --- ### **Innovation & Strategic Investments** #### **Strategic Growth Division & Startup Accelerator** - Established in **Sep 2025** with a dedicated fund of **₹50 million**. - Aims to invest in high-potential healthcare and wellness startups. - Provides portfolio companies with capital, mentorship, operational guidance, and access to Aayush’s distribution and R&D networks. - Aligns with long-term vision of driving innovation and scaling technology-led healthcare solutions in India. --- ### **Wellness Tourism – New Revenue Vertical** - Plans to invest **up to ₹30 crores over two years** to launch high-end wellness centers. - Offers holistic experiences: therapeutic yoga, Ayurvedic treatments, meditation, spa therapies, and nutritional counseling. - Taps into India’s **$21.31 billion wellness tourism market** (projected $26.55B by 2029), which faces limited organized supply. - Partnerships planned with government agencies, tourism boards, and private entities to establish domestic and international retreats. --- ### **Herbal Pan Masala – Disrupting a Traditional Market** - Launched **Aayush Herbal Pan Masala (Jun 2024)** as a tobacco-free, health-conscious alternative. - Targets India’s **₹46,682 crore pan masala market** and 27.49 crore tobacco users. - Supported by GATS2 survey (2019): ~29% of smokeless tobacco users want to quit. - Positioned to replicate traditional taste with herbal ingredients, appealing to health-aware consumers. - Pricing strategy: ₹10 sachets to drive first-time trials and scalable consumption. --- ### **Technology-Driven, Asset-Light Operating Model** - Partnerships with **Healthrashi Nextgen India Ltd (Sep 2025)** for AI-powered kiosks, mobile clinics, and automated diagnostic platforms. - Deploys **smart health ATMs**, mobile diagnostic units, and vending machines across corporates, banks, housing societies, and educational institutions. - Enables **scalable, affordable last-mile healthcare delivery** with minimal capital expenditure. - Reinforces Aayush’s vision as a **technology-enabled, preventive healthcare platform**. --- ### **Key Competitive Advantages** 1. **Multi-Vertical Integration:** Combines wellness, diagnostics, digital health, and tourism for a holistic ecosystem. 2. **Technology-First Approach:** AI, digital platforms, and smart diagnostics enable scalability and personalization. 3. **Omni-Channel Distribution:** Blends e-commerce, quick commerce (Blinkit), offline retail, and exports. 4. **Affordability & Accessibility:** ₹10 sachets and home delivery democratize wellness. 5. **Global Ambition with Local Roots:** Strong Indian heritage in Ayurveda with strategic global expansion via Singapore.